Hidenori Kitai, Philip H. Choi, Yu C. Yang, Jacob A. Boyer, Adele Whaley, Priya Pancholi, Claire Thant, Jason Reiter, Kevin Chen, Vladimir Markov, et al. Combined inhibition of KRASG12C and mTORC1 kinase is synergistic in non-small cell lung cancer. Nature Communications. 2024
Kitai H, Hiromichi Ebi. Oncogene alterations in non-small cell lung cancer with FGFR1 amplification-novel approach to stratify patients who benefit from FGFR inhibitors. Translational lung cancer research. 2024
Kosuke Tsuji, Eiki Kikuchi, Yuta Takashima, Tetsuaki Shoji, Hirofumi Takahashi, Shotaro Ito, Daisuke Morinaga, Masahiro Kashima, Makie Maeda, Hidenori Kitai, et al. Inhibition of non-homologous end joining mitigates paclitaxel resistance resulting from mitotic slippage in non-small cell lung cancer. Cell cycle (Georgetown, Tex.). 2023. 1-11
Hirokazu Taniguchi, Rebecca Caeser, Shweta S. Chavan, Yingqian A. Zhan, Andrew Chow, Parvathy Manoj, Fathema Uddin, Hidenori Kitai, Rui Qu, Omar Hayatt, et al. WEE1 inhibition enhances the antitumor immune response to PD-L1 blockade by the concomitant activation of STING and STAT1 pathways in SCLC. Cell Reports. 2022